Evidence map›Paper›PMID 42212368›Full record

ArticleMolecular medicine reports2026

[Retracted] Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP‑9 signaling pathway in DU145 cells.

Yuan Zeng, Ying Yang

Abstract readRetraction Notice
In one paragraph

Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Yuan ZengCollege of Life Sciences, Northwest University, Xi'an, Shaanxi 710069, P.R. China.
Ying YangCollege of Life Sciences, Northwest University, Xi'an, Shaanxi 710069, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that the cellular migration assay data shown in Fig. 5A‑C had either appeared previously, or were subsequently to appear, in a handful of other articles in different journals written by different authors at different research institutes, three of which have since been retracted. In addition, an independent analysis of the data in this paper undertaken by the Editorial Office revealed that western blot data featured in Fig. 6A on p. 6368 had also been included in five other papers written by different authors/research groups, the majority of which had already been published or were under consideration for publication when the above article was received at

Indexed as

DU145matrix metalloproteinase 9migrationpiperineprotein kinase B/mammalian target of rapamycin

Identifiers

PMID42212368
PMCPMC13244132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.